Characterization of human plasma proteome dynamics using deuterium oxide

Proteomics - Clinical Applications

Volumn 8, Issue 7-8, 2014, Pages 610-619

  Wang, Ding ^a,b   Liem, David A ^a,b   Lau, Edward ^a,b   Ng, Dominic C M ^a,b   Bleakley, Brian J ^b   Cadeiras, Martin ^a,b   Deng, Mario C ^a,b   Lam, Maggie P Y ^a,b   Ping, Peipei ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Deuterium oxide; Heavy water; Plasma proteome; Protein dynamics; Protein turnover

Indexed keywords

DEUTERIUM OXIDE; PLASMA PROTEIN; PROTEIN DERIVATIVE; PROTEOME;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; DEMOGRAPHY; FEASIBILITY STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR DYNAMICS; NORMAL HUMAN; PATIENT SAFETY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN METABOLISM; PROTEOME BLOOD LEVEL; REPRODUCIBILITY; YOUNG ADULT; BLOOD; CLINICAL TRIAL; METABOLISM; PROCEDURES; PROTEOMICS;

ADULT; BLOOD PROTEINS; DEUTERIUM OXIDE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; YOUNG ADULT;

EID: 84906058520     PISSN: 18628346     EISSN: 18628354     Source Type: Journal    
DOI: 10.1002/prca.201400038     Document Type: Article

References (33)

1. Claydon, A. J., Beynon, R., Proteome dynamics: revisiting turnover with a global perspective. Mol. Cell Proteomics 2012, 11, 1551-1565.
2. Balch, W. E., Morimoto, R. I., Dillin, A., Kelly, J. W., Adapting proteostasis for disease intervention. Science 2008, 319, 916-919.
3. Bano, D., Zanetti, F., Mende, Y., Nicotera, P., Neurodegenerative processes in Huntington's disease. Cell Death Dis. 2011, 2, e228.
4. Wang, X., Li, J., Zheng, H., Su, H., Powell, S. R., Proteasome functional insufficiency in cardiac pathogenesis. Am. J. Physiol. Heart Circ. Physiol. 2011, 301, H2207-H2219.
5. Nanjappa, V., Thomas, J. K., Marimuthu, A., Muthusamy, B. et al., Plasma proteome database as a resource for proteomics research: 2014 update. Nucleic Acids Res. 2014, 42, D959-D965.
6. Farrah, T., Deutsch, E. W., Omenn, G. S., Campbell, D. S. et al., A high-confidence human plasma proteome reference set with estimated concentrations in PeptideAtlas. Mol. Cell Proteomics 2011, 10, M110 006353.
7. Anderson, N. L., Anderson, N. G., The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell Proteomics 2002, 1, 845-867.
8. Berhane, B. T., Zong, C., Liem, D. A., Huang, A. et al., Cardiovascular-related proteins identified in human plasma by the HUPO Plasma Proteome Project pilot phase. Proteomics 2005, 5, 3520-3530.
9. Lam, M. P., Wang, D., Lau, E., Liem, D. et al., Protein kinetic signatures of the remodeling heart following isoproterenol stimulation. J. Clin. Invest 2014, 124, 1734-1744.
10. Kim, T. Y., Wang, D., Kim, A. K., Lau, E. et al., Metabolic labeling reveals proteome dynamics of mouse mitochondria. Mol. Cell Proteomics 2012, 11, 1586-1594.
11. Lam, M. P., Lau, E., Siu, S. O., Ng, D. C. et al., Online combination of reversed-phase/reversed-phase and porous graphitic carbon liquid chromatography for multicomponent separation of proteomics and glycoproteomics samples. Electrophoresis 2011, 32, 2930-2940.
12. Xu, T., Venable, J. D., Park, S. K., Cociorva, D. et al., ProLuCID, a fast and sensitive tandem mass spectra-based protein identification program. Mol. Cell Proteomics 2006, 5, S174.
13. Price, J. C., Holmes, W. E., Li, K. W., Floreani, N. A. et al., Measurement of human plasma proteome dynamics with (2)H(2)O and liquid chromatography tandem mass spectrometry. Anal. Biochem. 2012, 420, 73-83.
14. Jones, P. J., Leatherdale, S. T., Stable isotopes in clinical research: safety reaffirmed. Clin. Sci. 1991, 80, 277-280.
15. Katz, J. J., Crespi, H. L., Czajka, D. M., Finkel, A. J., Course of deuteriation and some physiological effects of deuterium in mice. Am. J. Physiol. 1962, 203, 907-913.
16. Hellerstein, M. K., Hoh, R. A., Hanley, M. B., Cesar, D. et al., Subpopulations of long-lived and short-lived T cells in advanced HIV-1 infection. J. Clin. Invest. 2003, 112, 956-966.
17. Messmer, B. T., Messmer, D., Allen, S. L., Kolitz, J. E. et al., In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells. J. Clin. Invest. 2005, 115, 755-764.
18. Busch, R., Neese, R. A., Awada, M., Hayes, G. M., Hellerstein, M. K., Measurement of cell proliferation by heavy water labeling. Nat. Protocols 2007, 2, 3045-3057.
19. Blagojevic, N., Storr, G., Allen, B. J., Hatanaka, H., Nakagawa, H., Role of heavy water in boron neutron capture therapy. in: Zamenhof, R., Solares, G., Harling, O. (Eds.), Topics in Dosimetry and Treatment Planning for Neutron Capture Therapy, Advanced Medical Publishing, Madison, WI, 1994, pp. 125-134.
20. Lewis, G. N., The biology of heavy water. Science 1934, 79, 151-153.
21. Rachdaoui, N., Austin, L., Kramer, E., Previs, M. J. et al., Measuring proteome dynamics in vivo: as easy as adding water? Mol. Cell Proteomics 2009, 8, 2653-2663.
22. Fanara, P., Wong, P. Y., Husted, K. H., Liu, S. et al., Cerebrospinal fluid-based kinetic biomarkers of axonal transport in monitoring neurodegeneration. J. Clin. Invest. 2012, 122, 3159-3169.
23. Emson, C. L., Fitzmaurice, S., Lindwall, G., Li, K. W. et al., A pilot study demonstrating a non-invasive method for the measurement of protein turnover in skin disorders: application to psoriasis. Clin. Transl. Med. 2013, 2, 12.
24. Schloerb, P. R., Friis-Hansen, B. J., Edelman, I. S., Solomon, A. K., Moore, F. D., The measurement of total body water in the human subject by deuterium oxide dilution; with a consideration of the dynamics of deuterium distribution. J. Clin. Invest. 1950, 29, 1296-1310.
25. Coward, W. A., Sawyer, M. B., Whitehead, R. G., Prentice, A. M., Evans, J., New method for measuring milk intakes in breast-fed babies. Lancet 1979, 2, 13-14.
26. Liem, D. A., Nsair, A., Setty, S. P., Cadeiras, M. et al., Molecular- and organelle-based predictive paradigm underlying recovery by left ventricular assist device support. Circ. Heart Fail 2014, 7, 359-366.
27. de Sain-van der Velden, M. G., Kaysen, G. A., de Meer, K., Stellaard, F. et al., Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: measurements with stable isotopes. Kidney Int. 1998, 53, 181-188.
28. Kekki, M., Koskelo, P., Nikkila, E. A., Turnover of iodine-131-labelled ceruloplasmin in human beings. Nature 1966, 209, 1252-1253.
29. Carraro, F., Rosenblatt, J., Wolfe, R. R., Isotopic determination of fibronectin synthesis in humans. Metabolism 1991, 40, 553-561.
30. Krauss, S., Haptoglobin metabolism in polycythemia vera. Blood 1969, 33, 865-876.
31. Shapiro, S. S., Martinez, J., Human prothrombin metabolism in normal man and in hypocoagulable subjects. J. Clin. Invest. 1969, 48, 1292-1298.
32. Katz, J. H., Iron and protein kinetics studied by means of doubly labeled human crystalline transferrin. J. Clin. Invest. 1961, 40, 2143-2152.
33. Socolow, E. L., Woeber, K. A., Purdy, R. H., Holloway, M. T., Ingbar, S. H., Preparation of I-131-labeled human serum prealbumin and its metabolism in normal and sick patients. J. Clin. Invest. 1965, 44, 1600-1609.